Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by DexterMorganon Jan 17, 2013 12:29am
181 Views
Post# 20848520

RE: RE: RE: RE: RE: RE: Big Bids SomeThing Is Cook

RE: RE: RE: RE: RE: RE: Big Bids SomeThing Is Cook

Cash on hand?  Burn Rate?  Well, the last round was 1.4Mill completed in March.  Since then, (f you take the time check out the news releases over the past year),  they have layered on a load of management payroll, promotion/IR, a whack of letter writers, Cunliffe, Advisors, Bloom Burton, Belenkie, Premack, Matthews and Associates etc. etc. etc.   Oh yeah, and there is a fully supported scientific team and laboratory in France.  A little rough math makes me think that its gotta be a pretty hefty burn rate.

So, let's see, that was 10 months plus ago.........to think that 1.4mill, or roughly 140,000 per month is carrying this load is hard to fathom.  Wouldn't you think with as much stock promotion activity (and likely a few paid pumpers!), managment, board members, operations and scientific/R&D development that the burn rate is likely more than this per month......I'm with biotech guy on this one guys.  Stop the rhetoric of "news coming".......if you really know so much and if it were to come then where is it? (it all smells a little insider to me)........this group should grow up and start to act like a real biotech company!  "Show me the money"........that's the news that we need to hear about.......jmho

Bullboard Posts